Literature DB >> 31128895

Pot smokers puffing away lung health.

Keerthi Yarlagadda1, Pratiksha Singh1, Isha Shrimanker2, Joshua C Hoffman3, Vinod K Nookala1.   

Abstract

BACKGROUND: Marijuana is the second most commonly used inhalational agent after tobacco. It has been used for therapeutic benefits in cancer, epilepsy, inflammation and pain. Inhalation of marijuana causes reversible and irreversible lung injury. CASE: We present a 26-year-old female with cough, chest pain, epistaxis, hemoptysis, night sweats and breathlessness few hours after smoking marijuana. Physical exam was positive for tachycardia, tachypnea, and diminished coarse breath sounds. Further investigation revealed elevated white blood cell count, chest X-ray, computed tomography of the chest showed bilateral patchy infiltrates. The patient was managed with short term steroid, as antibiotics alone did not work. Radiological improvement of lung injury was noted within 36-48 h.
CONCLUSION: There is a paucity of treatment guidelines for acute lung injury secondary to marijuana inhalation. We advocate early use of short-term steroids and also more awareness on quitting marijuana smoking to prevent life-threatening complications like myocardial infarction, diffuse alveolar hemorrhage and acute respiratory distress syndrome.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung injury; Marijuana; Smoking; Steroids

Mesh:

Year:  2019        PMID: 31128895     DOI: 10.1016/j.hrtlng.2019.05.010

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  2 in total

1.  Haemoptysis following shallow breath-hold diving in a cannabis user.

Authors:  Janice Borg; Julian Cassar; Sarah Bonello; Peter Fsadni
Journal:  BMJ Case Rep       Date:  2020-06-09

Review 2.  The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment.

Authors:  Estefanía Moreno; Milena Cavic; Ana Krivokuca; Enric I Canela
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.